BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31105018)

  • 1. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
    García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
    Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
    PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
    Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
    Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.
    Beyeler C; Reichen J; Thomann SR; Lauterburg BH; Gerber NJ
    Br J Rheumatol; 1997 Mar; 36(3):338-44. PubMed ID: 9133966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes.
    Quintin E; Scoazec JY; Marotte H; Miossec P
    Arthritis Res Ther; 2010; 12(4):R143. PubMed ID: 20637063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature.
    Visser K; van der Heijde DM
    Clin Exp Rheumatol; 2009; 27(6):1017-25. PubMed ID: 20149325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
    Choi SR; Park JW; Lee EB; Park JK
    Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Chen Z; Li XP; Li ZJ; Xu L; Li XM
    Int Immunopharmacol; 2013 Mar; 15(3):474-7. PubMed ID: 23415907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
    Teschke R; Méndez-Sánchez N; Eickhoff A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
    Asgarshirazi M; Shariat M; Sheikh M
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis Patients.
    Eektimmerman F; Swen JJ; den Broeder AA; Hazes JMW; Kurreeman FS; Verstappen SMM; Nair N; Pawlik A; Nurmohamed MT; Dolžan V; Böhringer S; Allaart CF; Guchelaar HJ
    Clin Pharmacol Ther; 2023 Apr; 113(4):916-923. PubMed ID: 36708065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
    Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF
    Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid.
    Suzuki Y; Uehara R; Tajima C; Noguchi A; Ide M; Ichikawa Y; Mizushima Y
    Scand J Rheumatol; 1999; 28(5):273-81. PubMed ID: 10568423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver diseases in rheumatoid and psoriatic arthritis].
    Santiago García D; Saturansky E; Poncino D; Ortiz V; Martínez Artola Y; Rosenberg S; Abritta G; Palermo C; Enriquez N; Cravero A
    Acta Gastroenterol Latinoam; 2012 Jun; 42(2):112-9. PubMed ID: 22876713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Amital H; Arnson Y; Chodick G; Shalev V
    Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.
    Kremer JM; Alarcón GS; Lightfoot RW; Willkens RF; Furst DE; Williams HJ; Dent PB; Weinblatt ME
    Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.